Literature DB >> 23260026

Approaches to virtual screening and screening library selection.

Scott A Wildman1.   

Abstract

The ease of access to virtual screening (VS) software in recent years has resulted in a large increase in literature reports. Over 300 publications in the last year report the use of virtual screening techniques to identify new chemical matter or present the development of new virtual screening techniques. The increased use is accompanied by a corresponding increase in misuse and misinterpretation of virtual screening results. This review aims to identify many of the common difficulties associated with virtual screening and allow researchers to better assess the reliability of their virtual screening effort.

Mesh:

Year:  2013        PMID: 23260026     DOI: 10.2174/1381612811319260009

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  4 in total

1.  Development and Testing of Druglike Screening Libraries.

Authors:  Junmei Wang; Yubin Ge; Xiang-Qun Xie
Journal:  J Chem Inf Model       Date:  2019-01-03       Impact factor: 4.956

2.  Machine Learning Consensus Scoring Improves Performance Across Targets in Structure-Based Virtual Screening.

Authors:  Spencer S Ericksen; Haozhen Wu; Huikun Zhang; Lauren A Michael; Michael A Newton; F Michael Hoffmann; Scott A Wildman
Journal:  J Chem Inf Model       Date:  2017-07-12       Impact factor: 4.956

Review 3.  The essential roles of chemistry in high-throughput screening triage.

Authors:  Jayme L Dahlin; Michael A Walters
Journal:  Future Med Chem       Date:  2014-07       Impact factor: 3.808

4.  Ligand-Based Virtual Screening, Molecular Docking, Molecular Dynamics, and MM-PBSA Calculations towards the Identification of Potential Novel Ricin Inhibitors.

Authors:  Fernanda D Botelho; Marcelo C Dos Santos; Arlan da S Gonçalves; Kamil Kuca; Martin Valis; Steven R LaPlante; Tanos C C França; Joyce S F D de Almeida
Journal:  Toxins (Basel)       Date:  2020-11-26       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.